|
This continues a steady rise in pay for the specialty—the same report recorded cardiology’s average salary as $430,000 in 2019, $423,000 in 2018 and $410,000 in 2017. This continues a steady rise in pay for the specialty—the same report recorded cardiology’s average salary as $430,000 in 2019, $423,000 in 2018 and $410,000 in 2017. | |
|
A 50-year-old cardiologist has died from complications related to COVID-19. A 50-year-old cardiologist has died from complications related to COVID-19. | |
|
The potential use of hydroxychloroquine to treat COVID-19 has been one of the biggest stories of the current pandemic. The potential use of hydroxychloroquine to treat COVID-19 has been one of the biggest stories of the current pandemic. | |
|
Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology. Heart transplant (HT) recipients have an increased risk of experiencing severe complications if infected with COVID-19, according to new findings published in JAMA Cardiology. | |
|
As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process. As COVID-19 patients begin to bounce back, they are sure to have plenty of important questions about the recovery process. | |
|
|
Royal Philips announced Wednesday, May 13, that its ultrasound imaging solutions have been cleared by the FDA for the management of cardiac and lung complications associated with COVID-19. Royal Philips announced Wednesday, May 13, that its ultrasound imaging solutions have been cleared by the FDA for the management of cardiac and lung complications associated with COVID-19. | |
|
The American College of Cardiology announced Monday, May 11, that it will start using two data registries to track and study the relationship between COVID-19 and heart disease. The American College of Cardiology announced Monday, May 11, that it will start using two data registries to track and study the relationship between COVID-19 and heart disease. | |
|
Mavacamten has demonstrated value as a treatment option for patients with obstructive hypertrophic cardiomyopathy (HCM), according to results from the EXPLORER-HCM phase III clinical trial. Mavacamten has demonstrated value as a treatment option for patients with obstructive hypertrophic cardiomyopathy (HCM), according to results from the EXPLORER-HCM phase III clinical trial. | |
|
Venous thromboembolism is a common complication among hospitalized patients, one that leads to longer lengths of stay and costs health systems up to $10 billion annually. Venous thromboembolism is a common complication among hospitalized patients, one that leads to longer lengths of stay and costs health systems up to $10 billion annually. | |
|
The algorithm, developed as part of a collaboration with Mayo Clinic, received Breakthrough Device designation back in December 2019. The algorithm, developed as part of a collaboration with Mayo Clinic, received Breakthrough Device designation back in December 2019. | |
|